SEC Form 4 · accession 0001237648-18-000016
HESKA CORP · HSKA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Asakowicz
Officer — EVP, Comp. Animal Health Sales
Period of report
Mar 7, 2018
Accepted (ET)
Mar 9, 2018 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001038133
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $69.77 | Mar 7, 2018 | A | 1,433 | A | — | Mar 6, 2028 | Common Stock | 1,433 | 1,433 | D |
| Non-Qualified Stock Option (right to buy)F1 | $69.77 | Mar 7, 2018 | A | 8,567 | A | — | Mar 6, 2028 | Common Stock | 8,567 | 8,567 | D |
| Performance SharesF2 | — | Mar 7, 2018 | A | 1,970 | A | — | Mar 31, 2025 | Common Stock | 1,970 | 1,970 | D |
Explanation of responses
- F1The aggregate of these two option awards vests in three approximately equal annual installments beginning on March 7, 2019 and ending on March 7, 2021.
- F2The vesting of each of three approximately equal performance share tranches is contingent on the achievement of certain market-vesting thresholds based on the price per share of Heska's common stock average over a 20-day trailing trading period. The first tranche is to vest at the later of the achievement of $87.21 per share or the second anniversary of grant date. The second tranche is to vest at the later of the achievement of $101.17 per share or the third anniversary of grant date. The third tranche is to vest at the later of the achievement of $122.10 per share or the fourth anniversary of grant date. Any performance shares that do not vest by March 31, 2025 are to be forfeited.